Boric acid


Curated chemical-gene interactions from CTD
Entrez gene IDGene symbolInteraction typeReference
1278 COL1A2 Affects expression PMID:24704097
1437 CSF2 Increases expression PMID:27206737
1440 CSF3 Increases expression PMID:27206737
16333 INS1 Increases expression PMID:31368021
16334 INS2 Increases expression PMID:31368021
1649 DDIT3 Decreases expression PMID:27587023
1674 DES Affects expression PMID:25637568
1728 NQO1 Increases expression PMID:30196486
207 AKT1 Increases expression PMID:31368021
22059 TRP53 Decreases expression PMID:31368021
2252 FGF7 Increases expression PMID:27206737
2335 FN1 Increases expression PMID:27206737
23645 PPP1R15A Increases expression PMID:27587023
249 ALPL Increases expression PMID:37045926
2597 GAPDH Decreases expression PMID:28285642
2645 GCK Increases expression PMID:31368021
2729 GCLC Increases expression PMID:30196486
2805 GOT1 Increases expression PMID:37045926
2875 GPT Increases expression PMID:37045926
3162 HMOX1 Increases expression PMID:30196486
3203 HOXA6 Affects expression PMID:12749385
3223 HOXC6 Affects expression PMID:12749385
3309 HSPA5 Increases expression PMID:25425213; PMID:27587023; PMID:27587023
3565 IL4 Increases expression PMID:31368021
3651 PDX1 Increases expression PMID:31368021
383 ARG1 Decreases activity PMID:21232540
3911 LAMA5 Increases expression PMID:27206737
406919 MIR130A Decreases expression PMID:34175401
406983 MIR200A Decreases expression PMID:34175401
406991 MIR21 Decreases expression PMID:34175401
407009 MIR224 Decreases expression PMID:34175401
4313 MMP2 Decreases expression PMID:28285642
4619 MYH1 Affects expression PMID:25637568
4654 MYOD1 Decreases expression PMID:25637568
4656 MYOG Affects expression PMID:25637568
468 ATF4 Increases expression PMID:25425213; PMID:27587023
4790 NFKB1 Increases expression PMID:31823256; PMID:37045926
5111 PCNA Increases expression PMID:17943231
581 BAX Affects expression PMID:31368021; PMID:34175401
59 ACTA2 Decreases expression PMID:25637568
595 CCND1 Increases expression PMID:28285642
596 BCL2 Affects expression PMID:31368021; PMID:34175401
598 BCL2L1 Decreases expression PMID:34175401
637 BID Increases expression PMID:34175401
6508 SLC4A3 Increases expression PMID:22576912
6514 SLC2A2 Increases expression PMID:31368021
6522 SLC4A2 Increases expression PMID:22576912
6647 SOD1 Decreases expression PMID:37045926
6678 SPARC Affects expression PMID:24704097
7040 TGFB1 Increases expression PMID:27206737; PMID:31368021
7097 TLR2 Increases expression PMID:37045926
7099 TLR4 Increases expression PMID:37045926
7124 TNF Affects expression PMID:31823256; PMID:37045926; PMID:9618283
7494 XBP1 Increases expression PMID:27587023
811 CALR Increases expression PMID:27587023
836 CASP3 Affects expression PMID:31368021; PMID:31823256; PMID:34175401
842 CASP9 Increases expression PMID:34175401
84447 SYVN1 Decreases expression PMID:27587023
847 CAT Decreases activity PMID:31823256
847 CAT Decreases expression PMID:37045926
860 RUNX2 Affects expression PMID:24704097
9695 EDEM1 Increases expression PMID:27587023
9709 HERPUD1 Increases expression PMID:27587023
DISCLAIMER

We have built a comprehensive resource which compiles potential endocrine disrupting chemicals (EDCs) based on the observed adverse effects or endocrine-mediated endpoints in published experiments on humans or rodents to support basic research. We are not responsible for any errors or omissions in the published research articles or supporting literature on potential EDCs compiled in this resource. Users are advised to exercise their own judgement on the weight of evidence for potential EDCs compiled in this resource. Importantly, our sole goal to build this resource on potential EDCs is to enable future basic research towards better understanding of the systems-level perturbations upon chemical exposure rather than influencing regulatory advice on chemical use.